Last updated on January 2020

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

Brief description of study

The purpose of this study is to determine the effectiveness of nivolumab adjuvant immunotherapy compared to placebo in adults and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recurrence.

Clinical Study Identifier: NCT04099251

Find a site near you

Start Over

Hopital Claude Huriez

LILLE Cedex, France
  Connect »